A promising breakthrough in vaccine storage and transport could drastically reduce the millions of vaccine doses wasted each year due to strict refrigeration requirements. Researchers in the UK have developed a powder-form vaccine technology inspired by plants that survive long dry spells, potentially improving access to life-saving immunizations, especially in low-resource regions.
- Powder vaccines remain stable for over a year without refrigeration.
- Inspired by plants that survive drought using a protective sugar.
- Could improve vaccine access in areas lacking reliable cold storage.
What happened
Scientists at the UK’s National Institute for Health and Care Research (NIHR) have developed a new method for producing vaccines in a powder form that stays stable without refrigeration. This innovation is based on the natural ability of “resurrection plants,” which survive months without water and revive when it rains. By using trehalose, a sugar these plants produce to protect their cells during drought, researchers stabilized a tetanus-diphtheria vaccine powder that can endure room temperature and extreme temperature changes.
Initial trials involving 60 people showed the powder vaccine to be safe, effective, and capable of producing immune responses comparable to traditional refrigerated vaccines. The vaccine powder remained viable after a year at room temperature and survived temperature cycling from freezing cold to high heat. A larger trial with 160 participants is planned to further validate these findings, potentially paving the way for this technology to reach wider use.
Why it feels good
This development addresses a major challenge in global health: vaccine spoilage due to broken cold chains. Many vaccines require constant refrigeration, but in many parts of the world—especially remote or low-resource areas—keeping vaccines cold is difficult or impossible. This often results in millions of doses being discarded every year, wasting resources and leaving vulnerable populations unprotected.
By removing the need for continuous refrigeration, the powder vaccine not only reduces waste but also improves vaccine accessibility for millions who may otherwise not receive timely immunizations. The approach leverages a simple, natural mechanism to overcome a complex logistical problem, offering hope that lifesaving vaccines can reach more people effectively and affordably.
What to enjoy or watch next
While newer mRNA vaccines are unlikely candidates for this powder technology, traditional vaccines used worldwide could benefit greatly. Watching how this method transforms vaccine distribution, especially in tropical and rural settings, will be inspiring and important for global health progress. Stay tuned for further updates as trials progress and practical applications emerge.